![](/img/cover-not-exists.png)
Open-label, Investigator-Initiated, Single Site Exploratory Trial Evaluating Secukinumab, an anti IL17A monoclonal antibody, for Patients with Moderate-to-Severe Hidradenitis Suppurativa
Prussick, L., Rothstein, B., Joshipura, D., Saraiya, A., Turkowski, Y., Abdat, R., Alomran, A., Zancanaro, P., Kachuk, C., Dumont, N., Gottlieb, A. B., Rosmarin, D.Language:
english
Journal:
British Journal of Dermatology
DOI:
10.1111/bjd.17822
Date:
February, 2019
File:
PDF, 406 KB
english, 2019